Research Article
E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes
Table 3
The association between E2F1 mRNA expression and clinicopathological characteristics in gastric cancer (
∗).
| Clinicopathological characteristics | Number of patients | E2F1 (−△△CT value) | value |
| Gender | | | 0.3910 | Male | 51 | 1.460 + 0.2977 | Female | 11 | 0.8645 + 0.5380 | Age (Years old) | | | 0.9699 | <63 | 26 | 1.366 + 0.3811 | ≥63 | 36 | 1.346 + 0.3637 | Differentiation | | | 0.0368∗ | Well, moderate | 16 | 0.4294 + 0.3463 | Poor | 46 | 1.676 + 0.3214 | Lymph node metastasis | | | 0.1303 | 0 | 19 | 0.7547 + 0.3995 | ≥1 | 43 | 1.619 + 0.3300 | Tumor size | | | 0.0125∗ | <4 | 25 | 0.5664 + 0.2620 | ≥4 | 37 | 1.887 + 0.3815 | T Stage | | | 0.0241∗ | T1-2 | 18 | 0.4361 + 0.3125 | T3-4 | 44 | 1.730 + 0.3330 | Ki67 positive rate (%) | | | 0.0913 | ≤30 | 24 | 0.7958 + 0.4324 | >30 | 38 | 1.707 + 0.3218 |
|
|